Clinical outcomes and documentation of partial beneficial effects of immunotherapy for multiple sclerosis

Ann Neurol. 1995 Jan;37(1):5-6. doi: 10.1002/ana.410370104.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Humans
  • Immunosuppression*
  • Methotrexate / therapeutic use*
  • Multiple Sclerosis / drug therapy*
  • Treatment Outcome

Substances

  • Methotrexate